FDA Inspection 969503 — Lapicor BVBA
The FDA completed an inspection of Lapicor BVBA on March 17, 2016 in Landen. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 17, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Landen (Belgium)